Ongoing management of late-onset CAP (occurring more than 72 hours after birth) in term neonates, and CAP in children younger than 2 months

If the patient has improved on the initial empirical therapy for sepsis or septic shock, and meningitis and encephalitis are excluded, the antibiotic regimens below can be used for late-onset community-acquired pneumonia (CAP) (occurring more than 72 hours after birth) in term neonates (gestational age 37 weeks or older) and CAP in children younger than 2 months. Seek expert advice for management of preterm neonates, patients who are not improving, or patients with complications of pneumonia such as parapneumonic effusion, empyema or lung abscess.

If available, modify treatment based on the results of investigations, including susceptibility testing – see Directed therapy for pneumonia.

Amoxicillin or ampicillin are recommended in these guidelines for ongoing empirical antibiotic therapy because of the possibility of Haemophilus influenzae and other gram-negative bacteria. However, if the child was initially treated with benzylpenicillin and is improving, it is reasonable to continue therapy rather than changing to amoxicillin or ampicillin.

For ongoing empirical antibiotic therapy for late-onset CAP (occurring more than 72 hours after birth) in term neonates (gestational age 37 weeks or older), and CAP in children younger than 2 months, use:

1amoxicillin 50 mg/kg intravenously; see advice on modification and duration of therapy amoxicillin

neonate 7 days or younger: 12-hourly

neonate older than 7 days: 8-hourly

child 1 to 2 months: 6-hourly

OR

1ampicillin 50 mg/kg intravenously; see advice on modification and duration of therapy ampicillin

neonate 7 days or younger: 12-hourly

neonate older than 7 days: 8-hourly

child 1 to 2 months: 6-hourly

PLUS with either of the above regimens

1gentamicin intravenously; see Principles of aminoglycoside use for prescribing considerations and subsequent dosing gentamicin

child 1 to 2 months: 7 mg/kg for initial dose

OR

1tobramycin intravenously; see Principles of aminoglycoside use for prescribing considerations and subsequent dosing tobramycin

child 1 to 2 months: 7 mg/kg for initial dose.

Review the response to empirical therapy and consider a shorter duration of therapy if the term neonate rapidly improves and the results of investigations indicate a viral aetiologyMahajan, 2018.